Page 2 - பிரிட்டன் ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tuesday 27 July 2021 - 4:00am Malaria is a mosquito-borne disease that kills more than 400,000 people a year, mainly children in Africa AFP/File | Olympia DE MAISMONT FRANKFURT - Germany s BioNTech, which developed a coronavirus vaccine with US giant Pfizer in record time, said Monday it aimed to start trialling a malaria vaccine next year using the same breakthrough mRNA technology. If successful, the vaccine could be a crucial step in the fight against the mosquito-borne disease, which kills more than 400,000 people a year mainly young children in Africa. We will do whatever it takes to develop a safe and effective mRNA-based malaria vaccine that will prevent the disease, reduce mortality and ensure a sustainable solution for the African continent and other regions affected by this disease, BioNTech CEO Ugur Sahin said in a statement.

Burkina fasoBiontech covidUgur sahinBritain oxford universityEuropean unionWorld health organizationEuropean commissionAfrica centers for diseaseAfrica centersDisease controlCommission president ursulaOxford universityபுர்கினா ஃபாஸொபிரிட்டன் ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம்ஐரோப்பிய தொழிற்சங்கம்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்